US Patent Issued to MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN on June 16 for "Ovarian cancer organoid culture" (German Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,655,394, issued on June 16, was assigned to MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (Munich).

"Ovarian cancer organoid culture" was invented by Thomas F. Meyer (Falkensee, Germany) and Mirjana Kessler (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for the production of a culture, e.g. an organoid culture of ovarian cancer or cancer precursor cells, particularly of high grade serous ovarian carcinoma cells. By means of this method, an organoid culture of ovarian cancer or cancer precursor cells and a biobank comprising a plurality of different organoid cultures of ovarian cancer or c...